Special populations in metastatic renal cell carcinoma.

IF 2.8 4区医学 Q2 ONCOLOGY

Current Opinion in Oncology Pub Date : 2024-02-23 DOI:10.1097/cco.0000000000001028

Taylor Goodstein, Ilana Goldberg, Yusuf Acikgoz, Elshad Hasanov, Ramaprasad Srinivasan, Eric A Singer

引用次数: 0

Abstract

This review focuses on special populations poorly represented in current evidence-based practice for metastatic renal cell carcinoma (mRCC). This includes the elderly and frail, patients on immunosuppression or with autoimmune diseases, patients with brain, liver, and/or bone metastases, and RCC with sarcomatoid features.

查看原文本刊更多论文

转移性肾细胞癌的特殊人群。

本综述重点关注在当前转移性肾细胞癌（mRCC）循证实践中代表性较差的特殊人群。其中包括年老体弱者、接受免疫抑制治疗或患有自身免疫性疾病的患者、脑、肝和/或骨转移患者，以及具有肉瘤特征的 RCC 患者。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Current Opinion in Oncology 医学-肿瘤学

CiteScore

6.10

自引率

2.90%

发文量

130

审稿时长

4-8 weeks

期刊介绍： With its easy-to-digest reviews on important advances in world literature, Current Opinion in Oncology offers expert evaluation on a wide range of topics from sixteen key disciplines including sarcomas, cancer biology, melanoma and endocrine tumors. Published bimonthly, each issue covers in detail the most pertinent advances in these fields from the previous year. This is supplemented by annotated references detailing the merits of the most important papers.